Xiangxue Pharmaceutical: The company has no products to treat hepatitis at the moment_Oriental Fortune Net

Post date May 6, 2022 — 18:48 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

The secretary of the board of CTI Testing replied: The company hopes to make a modest contribution to the fight against the epidemic – yqqlm

May 20, 2022 — 17:55

63 A-share chips changed hands (May 20) _ Oriental Fortune Net

May 20, 2022 — 17:50

Meichen Ecology: The company has not verified the effect of CBD on preventing new crown infection

May 20, 2022 — 17:50

China Testing and Testing: The company's PCR laboratory is operating normally

May 20, 2022 — 17:50

Jinlei shares: the company has been in a state of full production in the first quarter and April, and the capacity utilization rate is close to saturation

May 20, 2022 — 17:49

Ang Likang: The cumulative number of pledged shares of Shengzhou Juntai Investment Co., Ltd. is 16.77 million shares_ Oriental Fortune Net

May 20, 2022 — 17:46

Eating duck neck and drinking milk tea directly to Juewei Food's annual shareholders meeting is really "fragrant" scene

May 20, 2022 — 17:00

Can cooperation with Huawei directly limit the daily limit of National Star Optoelectronics Mini/Micro LED to become a breakthrough point in performance?

May 20, 2022 — 16:01

Luxshare Precision has been surveyed by 5 institutions: at this stage, what the company is doing is to rapidly integrate existing products, and accelerate the development of products that do not (with survey questions and answers)

May 20, 2022 — 16:00

Home » News » Xiangxue Pharmaceutical: The company has no products to treat hepatitis at the moment_Oriental Fortune Net